2025-07-13 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group Inc. (UNH) based on the data you provided, formatted for a professional report.

## UnitedHealth Group Inc. (UNH) Stock Analysis

**Ticker:** UNH
**Company Name:** UnitedHealth Group Inc.
**Company Overview:** UnitedHealth Group is a diversified healthcare company operating primarily in the United States.

### 1. Relative Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 20.60%
*   **VOO Cumulative Return:** 95.46%
*   **Absolute Divergence:** -77.4%
*   **Divergence Range:** Max: 55.3%, Min: -77.4%
*   **Relative Divergence:** 0.0%

**Analysis:**

UNH significantly underperformed the S&P 500 (VOO) over the analyzed period. The cumulative return is substantially lower, resulting in a divergence of -77.4%. The relative divergence of 0.0% suggests that UNH is currently at the lowest end of its historical divergence range compared to the S&P 500.

### 2. Alpha, Beta Analysis

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 65.0%  | 56.6% | 36.0%  | 0.0  | 200.0  |
| 2016-2018  | 52.0%  | 63.7% | 34.0%  | 0.0  | 226.0  |
| 2017-2019  | 38.0%  | 63.7% | 9.0%   | 0.3  | 266.7  |
| 2018-2020  | -21.0% | 63.7% | -40.0% | 0.4  | 318.1  |
| 2019-2021  | 36.0%  | 61.0% | -13.0% | 0.4  | 455.5  |
| 2020-2022  | 28.0%  | 66.9% | 26.0%  | 0.4  | 480.9  |
| 2021-2023  | 33.0%  | 67.5% | 15.0%  | 0.4  | 477.6  |
| 2022-2024  | -31.0% | 68.6% | -57.0% | 0.3  | 458.9  |
| 2023-2025  | -55.0% | 75.7% | -103.0%| 0.2  | 275.9  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** The CAGR has fluctuated significantly, with recent periods (2022-2025) showing negative growth.
*   **MDD (Maximum Drawdown):** The MDD is consistently high, indicating substantial potential losses from peak to trough.
*   **Alpha:** Alpha is negative for recent periods (2018-2025), suggesting underperformance relative to the benchmark.
*   **Beta:** Beta values are generally low (around 0.3-0.4), indicating lower volatility than the market.
*   **Market Cap:**  The market capitalization has fluctuated, showing substantial growth initially but declining in recent years.

### 3. Recent Stock Price Movements

*   **Current Price:** $304.10
*   **Previous Close:** $299.51
*   **Change:** 1.53%
*   **5-Day Moving Average:** $303.59
*   **20-Day Moving Average:** $307.67
*   **60-Day Moving Average:** $343.51

**Analysis:**

The stock price has increased slightly since the previous close.  The 5-day moving average is below the 20-day moving average, which is below the 60-day moving average, potentially signaling a short-term upward trend but overall downward momentum compared to the past 60 days. The recent positive change of 1.53% may reflect a short-term rebound.

### 4. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI (Relative Strength Index):** 51.43
*   **PPO (Percentage Price Oscillator):** 0.4461
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Delta Previous Relative Divergence:** -0.2 (Negative - Short-term decline)
*   **Expected Return:** 1205.6%

**Analysis:**

*   The MRI indicates a "Low Risk" environment.
*   The RSI of 51.43 is neutral, suggesting neither overbought nor oversold conditions.
*   The PPO of 0.4461 indicates a slight positive trend.
*   The "Hybrid Signal" suggests a cautious buying opportunity with 80% of cash allocated.
*   The negative change in relative divergence indicates a short-term downward trend compared to the S&P 500.
*   The extremely high "Expected Return" of 1205.6% should be viewed with extreme caution, as it represents a highly optimistic long-term projection of outperformance against the S&P 500 and is unlikely to be realized.

### 5. Recent News & Significant Events

*   **2025-07-13:** Major business developments, regulatory changes, or market events.
*   **2025-07-11:** Analyst discussions regarding recent performance and outlook.
*   **2025-07-09:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-12:** Market experts highlight both risks and opportunities.

**Analysis:**

Recent news suggests volatility and significant events impacting UNH, requiring close monitoring of company announcements and market trends.  Analysts' discussions and expert opinions should be considered for a comprehensive view.

### 6. Recent Earnings Analysis

| 날짜       | EPS    | 매출          |
|------------|--------|---------------|
| 2025-05-07 | 6.9    | 109.58 B$     |
| 2024-11-04 | 6.56   | 100.82 B$     |
| 2024-08-09 | 4.58   | 98.86 B$      |
| 2024-05-09 | -1.53  | 99.80 B$      |
| 2025-05-07 | -1.53  | 99.80 B$      |

**Analysis:**

The earnings data shows mixed performance.  Recent EPS figures (6.9 and 6.56) are positive, suggesting a recovery after previous negative EPS.  Revenue has generally increased over the period.  The duplicate entry for 2025-05-07 with negative EPS needs clarification.

### 7. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $109.58B  | 21.70%        |
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B   | 22.31%        |
| 2024-03-31 | $99.80B   | 23.05%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE    |
|------------|------------|--------|
| 2025-03-31 | $95.04B   | 6.62%  |
| 2024-12-31 | $92.66B   | 5.98%  |
| 2024-09-30 | $94.53B   | 6.41%  |
| 2024-06-30 | $89.36B   | 4.72%  |
| 2024-03-31 | $86.69B   | -1.63% |

**Analysis:**

*   **Revenue and Profitability:** Revenue has generally increased over the past five quarters, with a strong showing in the most recent quarter (2025-03-31). Profit margins remain relatively stable, hovering around 21-23%.
*   **Capital and Profitability:** Equity has also increased over the period. The Return on Equity (ROE) has improved significantly, moving from a negative value to a positive and increasing trend.  This indicates improved profitability relative to shareholder equity.

### 8. Overall Summary and Conclusion

UnitedHealth Group (UNH) presents a mixed picture. While recent earnings and revenue data indicate improved performance and profitability, the stock has significantly underperformed the S&P 500.  The historical alpha and beta analysis also reveal periods of underperformance. Technical indicators suggest a potential short-term upward trend but overall downward momentum compared to the past 60 days. Recent news highlights potential volatility and significant events that require close monitoring.  The MRI indicates a low-risk environment, but the negative delta in relative divergence suggests short-term weakness compared to the benchmark. The extremely high "Expected Return" should be viewed skeptically.

**Recommendation:**

Given the underperformance relative to the S&P 500, the high MDD, and the mixed technical signals, a cautious approach is warranted. Investors should closely monitor company news, analyst opinions, and further earnings reports before making investment decisions. While the MRI suggests low market risk, the negative divergence and recent volatility necessitate careful consideration.

**Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
